First Patient Enrolled in Merit Medical’s Multicenter Observational Study to Evaluate the Use of EmboCube® Embolization Gelatin to Control Bleeding or Hemorrhage

Source: Nasdaq GlobeNewswire / 05 Dec 2022 08:25:00   America/Chicago